Stay updated with breaking news from Annexon inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Annexon (NASDAQ:ANNX – Get Free Report) had its target price lowered by investment analysts at Needham & Company LLC from $24.00 to $16.00 in a note issued to investors on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. ANNX has been the subject of several other research reports. Wells Fargo […] ....
Research Analysts’ updated eps estimates for Monday, November 13th: Aadi Bioscience (NASDAQ:AADI) had its price target reduced by HC Wainwright from $45.00 to $36.00. HC Wainwright currently has a buy rating on the stock. Annexon (NASDAQ:ANNX) had its price target trimmed by Needham & Company LLC from $24.00 to $16.00. They currently have a buy […] ....
13.11.2023 - Company Prioritizes Greatest Near-term Value-Driving Programs: ANX005 for Guillain-Barré Syndrome (GBS), ANX007 for Geographic Atrophy (GA) and First-in-Kind Complement Small Molecule, ANX1502 ANX005 Phase 3 Pivotal Data in GBS On Track for . ....
North American Morning Briefing: Traders Await -2- morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.